Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma
published in: Leukemia & Lymphoma
date of publication: 2007-04-01
main subject: phase I clinical trial
Cites articles
There is nothing here
Article - wd:Q80206172